GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » Medifast Inc (NYSE:MED) » Definitions » Cyclically Adjusted Price-to-FCF

Medifast (Medifast) Cyclically Adjusted Price-to-FCF : 3.44 (As of May. 15, 2024)


View and export this data going back to 1981. Start your Free Trial

What is Medifast Cyclically Adjusted Price-to-FCF?

As of today (2024-05-15), Medifast's current share price is $25.15. Medifast's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $7.31. Medifast's Cyclically Adjusted Price-to-FCF for today is 3.44.

The historical rank and industry rank for Medifast's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

MED' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 3.42   Med: 33.79   Max: 118
Current: 3.62

During the past years, Medifast's highest Cyclically Adjusted Price-to-FCF was 118.00. The lowest was 3.42. And the median was 33.79.

MED's Cyclically Adjusted Price-to-FCF is ranked better than
88.89% of 27 companies
in the Personal Services industry
Industry Median: 13.83 vs MED: 3.62

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Medifast's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $0.497. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $7.31 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medifast Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Medifast's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medifast Cyclically Adjusted Price-to-FCF Chart

Medifast Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.80 50.20 46.01 18.79 9.14

Medifast Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.48 13.06 10.19 9.14 5.24

Competitive Comparison of Medifast's Cyclically Adjusted Price-to-FCF

For the Personal Services subindustry, Medifast's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medifast's Cyclically Adjusted Price-to-FCF Distribution in the Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Medifast's Cyclically Adjusted Price-to-FCF falls into.



Medifast Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Medifast's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=25.15/7.31
=3.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medifast's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Medifast's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.497/129.4194*129.4194
=0.497

Current CPI (Mar. 2024) = 129.4194.

Medifast Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.299 100.560 0.385
201409 0.563 100.428 0.726
201412 -0.158 99.070 -0.206
201503 0.754 99.621 0.980
201506 0.598 100.684 0.769
201509 0.768 100.392 0.990
201512 0.076 99.792 0.099
201603 0.636 100.470 0.819
201606 0.874 101.688 1.112
201609 0.473 101.861 0.601
201612 -0.096 101.863 -0.122
201703 0.517 102.862 0.650
201706 1.121 103.349 1.404
201709 0.922 104.136 1.146
201712 0.750 104.011 0.933
201803 1.378 105.290 1.694
201806 1.619 106.317 1.971
201809 0.479 106.507 0.582
201812 1.139 105.998 1.391
201903 2.311 107.251 2.789
201906 0.978 108.070 1.171
201909 1.297 108.329 1.550
201912 1.533 108.420 1.830
202003 2.236 108.902 2.657
202006 4.841 108.767 5.760
202009 3.192 109.815 3.762
202012 1.498 109.897 1.764
202103 5.111 111.754 5.919
202106 1.120 114.631 1.264
202109 0.459 115.734 0.513
202112 -1.627 117.630 -1.790
202203 3.494 121.301 3.728
202206 3.579 125.017 3.705
202209 4.857 125.227 5.020
202212 3.881 125.222 4.011
202303 5.683 127.348 5.775
202306 3.792 128.729 3.812
202309 2.584 129.860 2.575
202312 0.878 129.419 0.878
202403 0.497 129.419 0.497

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medifast  (NYSE:MED) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Medifast Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Medifast's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medifast (Medifast) Business Description

Traded in Other Exchanges
Address
100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
Executives
Jeffrey J Brown director 19900 MACARTHUR BLVD, SUITE 570, IRVINE CA 92612
Andrea B Thomas director C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Michael A. Hoer director MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202
Scott Schlackman director 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Hallquist Constance J. director 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Elizabeth A. Geary director C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Daniel R Chard director, officer: Chief Executive Officer NU SKIN ENTERPRISES, INC., 75 WEST CENTER STREET, PROVO UT 84601
Jonathan Barrett Mackenzie officer: VP, Finance & CAO 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Kevin G Byrnes director C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Michael C Macdonald director C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
James P. Maloney officer: Chief Financial Officer 415 HOLIDAY DRIVE, PITTSBURGH PA 15220
Ming Xian director MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202
Carl E Sassano director C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Joseph P Kelleman officer: (Interim) CFO 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Timothy G Robinson officer: Chief Financial Officer C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117